Trials / Active Not Recruiting
Active Not RecruitingNCT02818972
RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
A Prospective, Multicenter, Non-Blinded, Non-Randomized Study of the RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- Bolton Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Investigate the safety and effectiveness of the RelayPro Thoracic Stent-Grafts in subjects with thoracic aortic aneurysms (TAA) and penetrating atherosclerotic ulcers (PAU) of the descending thoracic aorta.
Detailed description
The objective of this study is to investigate the safety and effectiveness of the RelayPro Thoracic Stent-Grafts in subjects with thoracic aortic aneurysms and penetrating atherosclerotic ulcers of the descending thoracic aorta.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RelayPro | Endovascular treatment with investigational device. |
Timeline
- Start date
- 2017-05-10
- Primary completion
- 2022-06-24
- Completion
- 2025-12-01
- First posted
- 2016-06-30
- Last updated
- 2025-05-31
Locations
35 sites across 2 countries: United States, Japan
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02818972. Inclusion in this directory is not an endorsement.